The Research and Development team at Novasenta is responsible for identifying novel drug targets within the human tumor microenvironment through rigorous single-cell level analysis. Leveraging advanced data mining and computational biology, they accelerate the discovery and development of new antibody therapeutics with the goal of generating effective treatments for various cancers.